Nektar Therapeutics (NKTR) PT Raised to $63 at Evercore ISI; 'Highlights from 4Q earnings call'
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $63.65 +2.61%
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
20 Buy, 7 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
Evercore ISI raised its price target on Nektar Therapeutics (NASDAQ: NKTR) to $63.00 (from $31.00) while maintaining a In Line rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- MakeMyTrip (MMYT) PT Raised to $84 at Goldman Sachs
- Hyperscale Data acquires 48.5 acres to expand Michigan campus
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
